Yahoo India Web Search

Sign In

  1. Ad

    related to: Sio Gene Therapies
  2. www.creative-biolabs.com

    Gene Therapy Development - Gene Therapy Design

    Committed To Promoting Pharmaceutical Development With Our Expertise. Provide Customized and Comprehensive Gene Therapy Services for Basic and Clinical Research

    Free Consultant · 7-24 Delivery · One-Stop Full Service · cGMP manufacturing

    Service catalog: Delivery Systems, Gene Editing Service, RNAi Therapy Development

Search results

  1. siogtx.comSio Gene Therapies - Breaking the Boundaries of Gene Therapy

    Sio Gene Therapies, Inc. was a biotechnology company that developed gene therapies for rare diseases. It ceased operations and dissolved in April 2023 after a stockholder vote.

  2. en.wikipedia.org › wiki › Sio_Gene_TherapiesSio Gene Therapies - Wikipedia

    Sio Gene Therapies, Inc. (formerly known as Axovant Gene Therapies) was a clinical-stage pharmaceutical company that developed gene therapies to treat neurological disorders. The company was headquartered in New York City and was incorporated in Basel, Switzerland.

  3. Videos

    View all

  4. siogtx.com › aboutAbout | Sio Gene Therapies - siogtx.com

    Sio Gene Therapies is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease.

    • Sio Gene Therapies1
    • Sio Gene Therapies2
    • Sio Gene Therapies3
    • Sio Gene Therapies4
    • Sio Gene Therapies5

  5. www.biopharmadive.com › news › sio-gene-therapySio Gene Therapies to dissolve after years of setbacks

    Dec 15, 2022 · Following a monthslong business review, Sio Gene Therapies revealed Thursday plans to shut down the company and liquidate its assets. The plan, put forward by the company’s board of directors, will need to win shareholder approval at a meeting slated to take place in the first quarter.

  6. www.globenewswire.com › news-release › 2021/11/01Sio Gene Therapies Announces Granting of FDA Fast Track

    Nov 1, 2021 · Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients.

  7. finance.yahoo.com › news › sio-gene-therapiesSio Gene Therapies Announces Granting of FDA Fast Track ...

    Oct 21, 2021 · NEW YORK and DURHAM, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the...

  8. www.biospace.com › article › releasesSio Gene Therapies, Inc. to File for Dissolution and Declare ...

    Feb 2, 2024 · Sio was a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Sio ceased its development programs in mid-2022. Its stockholders voted to dissolve Sio and its remaining 3 foreign subsidiaries in April 2023.